Caricamento...
Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease
Nonmetastatic castration-resistant prostate cancer (nmCRPC) - defined as prostate-specific antigen (PSA) > 2 ng/mL, testosterone castration levels < 1.7 nm/L, and the absence of metastatic lesions on conventional imaging (computed tomography or bone scan) - has been defined as a lethal disease...
Salvato in:
| Pubblicato in: | World J Clin Oncol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Inc
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7829629/ https://ncbi.nlm.nih.gov/pubmed/33552935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v12.i1.6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|